Abstract
Hereditary cancer syndromes are responsible for 5% of endometrial cancers and 10% of ovarian cancers. Hereditary breast and ovarian cancer syndrome and Lynch syndrome account for most of these inherited cases. Significant advances have been made in the identification and management of women with these syndromes. In addition, recent advances have highlighted the prognostic and therapeutic implications for women with gynecologic cancers and inherited cancer syndromes.
Original language | English (US) |
---|---|
Pages (from-to) | 13-29 |
Number of pages | 17 |
Journal | Hematology/Oncology Clinics of North America |
Volume | 26 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2012 |
Keywords
- BRCA
- Genetic
- Gynecologic cancer
- Lynch syndrome
ASJC Scopus subject areas
- Hematology
- Oncology